BRCA2 Abrogation Triggers Innate Immune Responses Potentiated by Treatment With PARP Inhibitors
Nature Communications - United Kingdom
doi 10.1038/s41467-019-11048-5
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2019
Authors
Publisher
Springer Science and Business Media LLC